Recent research has demonstrated that CBD can target the expression of Kelch-like ECH-associated protein 1 (Keap1) and Nrf2 in pulmonary artery smooth muscle cells, potentially boosting its antioxidant benefits in a model of pulmonary arterial hypertension (96). Here, KEAP1 is linked to pulmonary arterial hypertension.